Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 75.

Wild, P J; Kristiansen, G (2016). Sitzungsbericht der Arbeitsgemeinschaft Uropathologie der Deutschen Gesellschaft für Pathologie 2016. Der Pathologe, 37(Suppl 2):256-257.

Huber, F; Montani, M; Sulser, T; Jaggi, R; Wild, P; Moch, H; Gevensleben, H; Schmid, M; Wyder, S; Kristiansen, G (2015). Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer-what has gone wrong? A blueprint for the way forward in biomarker studies. British Journal of Cancer, 112:140-148.

Wottawa, M; Leisering, P; von Ahlen, Melanie; Schnelle, M; Vogel, S; Malz, C; Bordoli, R M; Camenisch, G; Hesse, A; Napp, J; Alves Cardoso, F; Kristiansen, G; Farhat, K; Katschinski, D M (2013). Knockdown of prolyl-4-hydroxylase domain 2 inhibits tumor growth of human breast cancer MDA-MB-231 cells by affecting TGF-b1 processing. International Journal of Cancer, 132(12):2787-2798.

Bretz, N; Noske, A; Keller, S; Erbe-Hofmann, N; Schlange, T; Salnikov, A V; Moldenhauer, G; Kristiansen, G; Altevogt, P (2012). CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion. Clinical and Experimental Metastasis, 29(1):27-38.

Mazur, P K; Riener, M O; Jochum, W; Kristiansen, G; Weber, A; Schmid, R M; Siveke, J T (2012). Expression and clinicopathological significance of notch signaling and cell-fate genes in biliary tract cancer. American Journal of Gastroenterology, 107(1):126-135.

Gerhardt, J; Montani, M; Wild, P J; Beer, M; Huber, F; Hermanns, T; Müntener, M; Kristiansen, G (2012). FOXA1 promotes tumor progression in prostate cancer and represents a novel hallmark of castration-resistant prostate cancer. American Journal of Pathology, 180(2):848-861.

Algaba, F; Delahunt, B; Berney, D M; Camparo, P; Compérat, E; Griffiths, D; Kristiansen, G; Lopez-Beltran, A; Martignoni, G; Moch, H; Montironi, R; Varma, M; Egevad, L (2012). Handling and reporting of nephrectomy specimens for adult renal tumours: a survey by the European Network of Uropathology. Journal of Clinical Pathology, 65(2):106-113.

Stiehl, D P; Bordoli, M R; Abreu-Rodríguez, I; Wollenick, K; Schraml, P; Gradin, K; Poellinger, L; Kristiansen, G; Wenger, R H (2012). Non-canonical HIF-2alpha function drives autonomous breast cancer cell growth via an AREG-EGFR/ErbB4 autocrine loop. Oncogene, 31(18):2283-2297.

Beer, M; Montani, M; Gerhardt, J; Wild, P J; Hany, T F; Hermanns, T; Müntener, M; Kristiansen, G (2012). Profiling gastrin-releasing peptide receptor in prostate tissues: Clinical implications and molecular correlates. Prostate, 72(3):318-325.

Wollenick, K; Hu, J; Kristiansen, G; Schraml, P; Rehrauer, H; Berchner-Pfannschmidt, U; Fandrey, J; Wenger, R H; Stiehl, D P (2012). Synthetic transactivation screening reveals ETV4 as broad coactivator of hypoxia-inducible factor signaling. Nucleic Acids Research, 40(5):1928-1943.

Varga, Z; Moelans, C B; Zuerrer-Hardi, U; Ramach, C; Behnke, S; Kristiansen, G; Moch, H (2012). Topoisomerase 2A gene amplification in breast cancer. Critical evaluation of different FISH probes. Breast Cancer Research and Treatment, 133(3):929-935.

Noske, A; Zimmermann, A K; Caduff, R; Varga, Z; Fink, D; Moch, H; Kristiansen, G (2011). Alpha-methylacyl-CoA racemase (AMACR) expression in epithelial ovarian cancer. Virchows Archiv, 459(1):91-97.

Kristiansen, G; Hu, J; Wichmann, D; Stiehl, D P; Rose, M; Gerhardt, J; Bohnert, A; Ten Haaf, A; Moch, H; Raleigh, J; Varia, M A; Subarsky, P; Scandurra, F M; Gnaiger, E; Gleixner, E; Bicker, A; Gassmann, M; Hankeln, T; Dahl, E; Gorr, T A (2011). Endogenous myoglobin in breast cancer is hypoxia-inducible by alternative transcription and functions to impair mitochondrial activity: a role in tumor suppression? Journal of Biological Chemistry, 286(50):43417-43428.

Fritzsche, F R; Hasler, A; Bode, P K; Adams, H; Seifert, H H; Sulser, T; Moch, H; Barghorn, A; Kristiansen, G (2011). Expression of histone deacetylases 1, 2 and 3 in histological subtypes of testicular germ cell tumours. Histology and Histopathology, 26(12):1555-1561.

Kilian, M; Heukamp, I; Gregor, J I; Schimke, I; Kristiansen, G; Wenger, F A (2011). Fish oil, but not soy bean or olive oil enriched infusion decreases histopathological severity of acute pancreatitis in rats without affecting eicosanoid synthesis. Inflammation, 34(6):597-602.

Egevad, L; Algaba, F; Berney, D M; Boccon-Gibod, L; Compérat, E; Evans, A J; Grobholz, R; Kristiansen, G; Langner, C; Lockwood, G; Lopez-Beltran, A; Montironi, R; Oliveira, P; Schwenkglenks, M; Vainer, B; Varma, M; Verger, V; Camparo, P (2011). Interactive digital slides with heat maps: a novel method to improve the reproducibility of Gleason grading. Virchows Archiv, 459(2):175-182.

Mortezavi, A; Hermanns, T; Seifert, H H; Baumgartner, M; Provenzano, M; Sulser, T; Burger, M; Montani, M; Ikenberg, K; Hofstaedter, F; Hartmann, A; Jaggi, R; Moch, H; Kristiansen, G; Wild, P J (2011). KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clinical Cancer Research, 17(5):1111-1121.

Doberstein, K; Schramme, A; Lee, S B; Blaheta, R A; Wedel, S; Moch, H; Schraml, P; Pfeilschifter, J; Kristiansen, G; Gutwein, P (2011). L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cells. Carcinogenesis, 32(3):262-270.

Tischler, V; Pfeifer, M; Hausladen, S; Schirmer, U; Bonde, A K; Kristiansen, G; Sos, M L; Weder, W; Moch, H; Altevogt, P; Soltermann, A (2011). L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer. Molecular Cancer, 10:127.

Bode, P K; Barghorn, A; Fritzsche, F R; Riener, M O; Kristiansen, G; Knuth, A; Moch, H (2011). MAGEC2 is a sensitive and novel marker for seminoma: a tissue microarray analysis of 325 testicular germ cell tumors. Modern Pathology, 24(6):829-835.

Gorr, T A; Wichmann, D; Pilarsky, C; Theurillat, J P; Fabrizius, A; Laufs, T; Bauer, T; Koslowski, M; Horn, S; Burmester, T; Hankeln, T; Kristiansen, G (2011). Old proteins - new locations: myoglobin, haemoglobin, neuroglobin and cytoglobin in solid tumours and cancer cells. Acta Physiologica, 202(3):563-581.

Bordoli, M R; Stiehl, D P; Borsig, L; Kristiansen, G; Hausladen, S; Schraml, P; Wenger, R H; Camenisch, G (2011). Prolyl-4-hydroxylase PHD2- and hypoxia-inducible factor 2-dependent regulation of amphiregulin contributes to breast tumorigenesis. Oncogene, 30(5):548-560.

Morra, L; Rechsteiner, M; Casagrande, S; Duc Luu, V; Santimaria, R; Diener, P A; Sulser, T; Kristiansen, G; Schraml, P; Moch, H; Soltermann, A (2011). Relevance of periostin splice variants in renal cell carcinoma. American Journal of Pathology, 179(3):1513-1521.

Riener, M O; Kristiansen, G (2011). S100P, von Hippel-Lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy. Human Pathology, 42(9):1368-author reply 1368-1369.

Jentzmik, F; Stephan, C; Lein, M; Miller, K; Kamlage, B; Bethan, B; Kristiansen, G; Jung, K (2011). Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression. The Journal of Urology, 185(2):706-711.

Gerhardt, J; Steinbrech, C; Büchi, O; Behnke, S; Bohnert, A; Fritzsche, F; Liewen, H; Stenner, F; Wild, P; Hermanns, T; Müntener, M; Dietel, M; Jung, K; Stephan, C; Kristiansen, G (2011). The androgen-regulated Calcium-Activated Nucleotidase 1 (CANT1) is commonly overexpressed in prostate cancer and is tumor-biologically relevant in vitro. American Journal of Pathology, 178(4):1847-1860.

Riener, M O; Vogetseder, A; Pestalozzi, B C; Clavien, P A; Probst-Hensch, N; Kristiansen, G; Jochum, W (2010). Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract. Human Pathology, 41(11):1558-1565.

Kristiansen, G; Rose, M; Geisler, C; Fritzsche, F R; Gerhardt, J; Lüke, C; Ladhoff, A-M; Knüchel, R; Dietel, M; Moch, H; Varga, Z; Theurillat, J-P; Gorr, T A; Dahl, E (2010). Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype. British Journal of Cancer, 102(12):1736-1745.

Schaefer, A; Jung, M; Kristiansen, G; Lein, M; Schrader, M; Miller, K; Stephan, C; Jung, K (2010). MicroRNAs and cancer: current state and future perspectives in urologic oncology. Urologic Oncology, 28(1):4-13.

Fritzsche, F R; Bode, P K; Moch, H; Kristiansen, G; Varga, Z; Bode, B (2010). Determination of the Her-2/neu gene amplification status in cytologic breast cancer specimens using automated silver-enhanced in-situ hybridization (SISH). American Journal of Surgical Pathology, 34(8):1180-1185.

Scheble, V J; Braun, M; Wilbertz, T; Stiedl, A C; Petersen, K F; Schilling, D; Reischl, M; Seitz, G; Fend, F; Kristiansen, G; Perner, S (2010). ERG rearrangement in small cell prostatic and lung cancer. Histopathology, 56(7):937-943.

Riener, M O; Fritzsche, F R; Soll, C; Pestalozzi, B C; Probst-Hensch, N M; Clavien, P A; Jochum, W; Soltermann, A; Moch, H; Kristiansen, G (2010). Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas. Histopathology, 56(5):600-606.

Xu, Y; Bismar, T A; Su, J; Xu, B; Kristiansen, G; Varga, Z; Teng, L; Ingber, D E; Mammoto, A; Kumar, R; Alaoui-Jamali, M A (2010). Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion. Journal of Experimental Medicine, 207(11):2421-2437.

Fritzsche, F R; Kristiansen, G; Riener, M-O; Dietel, M; Oelrich, B (2010). GOLPH2 expression may serve as diagnostic marker in seminomas. BMC Urology, 10:4.

Eisenring, M; vom Berg, J; Kristiansen, G; Saller, E; Becher, B (2010). IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46. Nature Immunology, 11(11):1030-1038.

Ikenberg, K; Fritzsche, F R; Zuerrer-Haerdi, U; Hofmann, I; Hermanns, T; Seifert, H; Müntener, M; Provenzano, M; Sulser, T; Behnke, S; Gerhardt, J; Mortezavi, A; Wild, P; Hofstädter, F; Burger, M; Moch, H; Kristiansen, G (2010). Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores. BMC Cancer, 10:341.

Dahinden, C; Ingold, B; Wild, P; Boysen, G; Luu, V D; Montani, M; Kristiansen, G; Sulser, T; Bühlmann, P; Moch, H; Schraml, P (2010). Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer. Clinical Cancer Research, 16(1):88-98.

Fritzsche, F R; Reineke, T; Morawietz, L; Kristiansen, G; Dietel, M; Fink, D; Rageth, C; Honegger, C; Caduff, R; Moch, H; Varga, Z (2010). Pathological processing techniques and final diagnosis of breast cancer sentinel lymph nodes. Annals of Surgical Oncology, 17(11):2892-2898.

Tischler, V; Fritzsche, F R; Wild, P J; Stephan, C; Seifert, H H; Riener, M O; Hermanns, T; Mortezavi, A; Gerhardt, J; Schraml, P; Jung, K; Moch, H; Soltermann, A; Kristiansen, G (2010). Periostin is up-regulated in high grade and high stage prostate cancer. BMC Cancer, 10:273.

Esgueva, R; Perner, S; Lafargue, C J; Scheble, V; Stephan, C; Lein, M; Fritzsche, F R; Dietel, M; Kristiansen, G; Rubin, M A (2010). Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort. Modern Pathology, (23):539-546.

May, M; Brookman-Amissah, S; Roigas, J; Hartmann, A; Störkel, S; Kristiansen, G; Gilfrich, C; Borchardt, R; Hoschke, B; Kaufmann, O; Gunia, S (2010). Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications. European Urology, 57(5):850-858.

Fritzsche, F R; Tutic, M; Opitz, I; Hunziker, R; Kristiansen, G; Montani, M (2010). Pulmonary Kaposi's sarcoma after heart transplantation: a case report. Journal of Medical Case Reports, 4:206.

Montani, M; Thiesler, T; Kristiansen, G (2010). Smoothelin is a specific and robust marker for distinction of muscularis propria and muscularis mucosae in the gastrointestinal tract. Histopathology, 57(2):244-249.

Kristiansen, G (2009). Manual microdissection. In: Walker, J M. Cancer Gene Profiling. Heidelberg: Springer, 31-38.

Fritzsche, F R; Kristiansen, G; Frauenfelder, T; Opitz, I; Bode, P; Moch, H; Montani, M (2009). Large mixed germ cell tumor in a young patient presenting as an intrapulmonary mass. Pathology - Research and Practice, 205(8):572-578.

Wild, P J; Fuchs, T; Stoehr, R; Zimmermann, D; Frigerio, S; Padberg, B; Steiner, I; Zwarthoff, E C; Burger, M; Denzinger, S; Hofstaedter, F; Kristiansen, G; Hermanns, T; Seifert, H H; Provenzano, M; Sulser, T; Roth, V; Buhmann, J M; Moch, H; Hartmann, A (2009). Detection of Urothelial Bladder Cancer Cells in Voided Urine Can Be Improved by a Combination of Cytology and Standardized Microsatellite Analysis. Cancer Epidemiology Biomarkers & Prevention, 18(6):1798-1806.

Gutwein, P; Schramme, A; Voss, B; Abdel-Bakky, M S; Doberstein, K; Ludwig, A; Altevogt, P; Hansmann, M L; Moch, H; Kristiansen, G; Pfeilschifter, J (2009). Downregulation of junctional adhesion molecule-A is involved in the progression of clear cell renal cell carcinoma. Biochemical and Biophysical Research Communications (BBRC), 380(2):387-391.

Meyer, H A; Tölle, A; Jung, M; Fritzsche, F R; Haendler, B; Kristiansen, I; Gaspert, A; Johannsen, M; Jung, K; Kristiansen, G (2009). Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma. European Urology, 55(3):669-678.

Gutwein, P; Schramme, A; Sinke, N; Abdel-Bakky, M S; Voss, B; Obermüller, N; Doberstein, K; Koziolek, M; Fritzsche, F; Johannsen, M; Jung, K; Schaider, H; Altevogt, P; Ludwig, A; Pfeilschifter, J; Kristiansen, G (2009). Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients. European Journal of Cancer, 45(3):478-489.

Riener, M O; Stenner, F; Liewen, H; Soll, C; Breitenstein, S; Pestalozzi, B C; Samaras, P; Probst-Hensch, N M; Hellerbrand, C; Müllhaupt, B; Clavien, P A; Bahra, M; Neuhaus, P; Wild, P; Fritzsche, F; Moch, H; Jochum, W; Kristiansen, G (2009). Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology, 49(5):1602 -1609.

Riener, M O; Stenner, F; Liewen, H; Hellerbrand, C; Bahra, M; Kristiansen, G (2009). Alpha-fetoprotein and serum golgi phosphoprotein 2 are equally discriminative in detecting early hepatocellular carcinomas. Hepatology, 50(1):326.

Dietrich, D; Lesche, R; Tetzner, R; Krispin, M; Dietrich, J; Haedicke, W; Schuster, M; Kristiansen, G (2009). Analysis of DNA methylation of multiple genes in microdissected cells from formalin-fixed and paraffin-embedded tissues. Journal of Histochemistry and Cytochemistry, 57(5):477-489.

Tölle, A; Jung, M; Lein, M; Johannsen, M; Miller, K; Moch, H; Jung, K; Kristiansen, G (2009). Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer? BMC Cancer, 9:248.

Weiss, G; Cottrell, S; Distler, J; Schatz, P; Kristiansen, G; Ittmann, M; Haefliger, C; Lesche, R; Hartmann, A; Corman, J; Wheeler, T (2009). DNA methylation of the PITX2 gene promoter region is a strong independent prognostic marker of biochemical recurrence in patients with prostate cancer after radical prostatectomy. The Journal of Urology, 181(4):1678-1685.

Kempkensteffen, C; Fritzsche, F R; Johannsen, M; Weikert, S; Hinz, S; Dietel, M; Riener, M O; Moch, H; Jung, K; Krause, H; Miller, K; Kristiansen, G (2009). Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer. BMC Cancer, 9:276.

Lehmann, A; Denkert, C; Budczies, J; Buckendahl, A C; Darb-Esfahani, S; Noske, A; Müller, B M; Bahra, M; Neuhaus, P; Dietel, M; Kristiansen, G; Weichert, W (2009). High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo. BMC Cancer, 9:395.

Riener, M O; Fritzsche, F R; Clavien, P A; Pestalozzi, B C; Probst-Hensch, N; Jochum, W; Kristiansen, G (2009). IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas. Human Pathology, 40(10):1377-1383.

Fritzsche, F R; Kristiansen, G (2009). Influence of drinking habits of pathologists on publications. Journal of Clinical Pathology, 62(3):288.

Schaefer, A; Jung, M; Kristiansen, G; Lein, M; Schrader, M; Miller, K; Erbersdobler, A; Stephan, C; Jung, K (2009). Mikro-RNA in der Uroonkologie. Neue Hoffnungen für die Diagnostik und Therapie von Tumoren? Der Urologe. Ausg. A, 48(8):877-885.

Baumhoer, D; Riener, M O; Zlobec, I; Tornillo, L; Vogetseder, A; Kristiansen, G; Dietmaier, W; Hartmann, A; Wuensch, P H; Sessa, F; Ruemmele, P; Terracciano, L M (2008). Expression of CD24, P-cadherin and S100A4 in tumors of the ampulla of Vater. Modern Pathology, 22:306-313.

Soltermann, A; Tischler, V; Arbogast, S; Braun, J; Probst-Hensch, N M; Weder, W; Moch, H; Kristiansen, G (2008). Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clinical Cancer Research, 14(22):7430-7437.

Umbehr, M; Kessler, T M; Sulser, T; Kristiansen, G; Probst, N; Steurer, J; Bachmann, L M (2008). ProCOC: the prostate cancer outcomes cohort study. BMC Urology, 8:9.

Fritzsche, F R; Jung, M; Tölle, A; Wild, P; Hartmann, A; Wassermann, K; Rabien, A; Lein, M; Dietel, M; Pilarsky, C; Calvano, D; Grützmann, R; Jung, K; Kristiansen, G (2008). ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer. European Urology, 54(5):1097-1108.

Fritzsche, F R; Wassermann, K; Jung, M; Tölle, A; Kristiansen, I; Lein, M; Johannsen, M; Dietel, M; Jung, K; Kristiansen, G (2008). ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression. BMC Cancer, 8:179.

Fritzsche, F R; Oelrich, B; Johannsen, M; Kristiansen, I; Moch, H; Jung, K; Kristiansen, G (2008). Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas. Clinical Cancer Research, 14(21):7035-7042.

Gunia, S; May, M; Scholmann, K; Störkel, S; Hoschke, B; Koch, S; Dietel, M; Kristiansen, G (2008). Expression of alpha-methylacyl-CoA racemase correlates with histopathologic grading in noninvasive bladder cancer. Virchows Archiv, 453(2):165-170.

Hamm, A; Veeck, J; Bektas, N; Wild, P J; Hartmann, A; Heindrichs, U; Kristiansen, G; Werbowetski-Ogilvie, T; Del Maestro, R; Knuechel, R; Dahl, E (2008). Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis. BMC Cancer, 8:25.

Fritzsche, F R; Riener, M O; Dietel, M; Moch, H; Jung, K; Kristiansen, G (2008). GOLPH2 expression in renal cell cancer. BMC Urology, 8:15.

Kristiansen, G; Fritzsche, F R; Wassermann, K; Jäger, C; Tölle, A; Lein, M; Stephan, C; Jung, K; Pilarsky, C; Dietel, M; Moch, H (2008). GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. British Journal of Cancer, 99(6):939-948.

Weichert, W; Röske, A; Gekeler, V; Beckers, T; Stephan, C; Jung, K; Fritzsche, F R; Niesporek, S; Denkert, C; Dietel, M; Kristiansen, G (2008). Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy. British Journal of Cancer, 98(3):604-610.

Harbeck, N; Nimmrich, I; Hartmann, A; Ross, J S; Cufer, T; Grützmann, R; Kristiansen, G; Paradiso, A; Hartmann, O; Margossian, A; Martens, J; Schwope, I; Lukas, A; Müller, V; Milde-Langosch, K; Nährig, J; Foekens, J; Maier, S; Schmitt, M; Lesche, R (2008). Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients. Journal of Clinical Oncology, 26(31):5036-5042.

Veeck, J; Chorovicer, M; Naami, A; Breuer, E; Zafrakas, M; Bektas, N; Dürst, M; Kristiansen, G; Wild, P J; Hartmann, A; Knuechel, R; Dahl, E (2008). The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation. Oncogene, 27(6):865-876.

Bektas, N; Noetzel, E; Veeck, J; Press, M F; Kristiansen, G; Naami, A; Hartmann, A; Dimmler, A; Beckmann, M W; Knüchel, R; Fasching, P A; Dahl, E (2008). The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer. Breast Cancer Research, 10(R58):4.

Fritzsche, F R; Dietel, M; Kristiansen, G (2008). Where we publish: an analysis of the publications of German institutes of pathology. Virchows Archiv, 452(4):363-368.

Dietel, M; Ellis, I O; Höfler, H; Kreipe, H; Moch, H; Dankof, A; Kölble, K; Kristiansen, G (2007). Comparison of automated silver enhanced in situ hybridisation (SISH) and fluorescence ISH (FISH) for the validation of HER2 gene status in breast carcinoma according to the guidelines of the American Society of Clinical Oncology and the College of American Pathologists. Virchows Archiv, 451(1):19-25.

This list was generated on Tue Nov 21 09:23:09 2017 CET.